Drug retailer Walgreen Co is buying a 45 percent stake in European health and beauty group Alliance Boots for $6.7 billion in cash and stock, creating the world's biggest buyer of prescription drugs.
- Together Walgreens and Alliance Boots are uniquely positioned to anticipate the rapidly changing global health and wellbeing marketplace to the benefit of customers, employees and business partners ...
LONDON — Andy Hornby has been named group chief executive of Alliance Boots, the health-and-beauty retailer and pharmaceuticals wholesaler. He will take on the new role July 1 and will report to ...
Shortly after private equity firm Kohlberg Kravis Roberts & Co. and Alliance Boots’ executive deputy chairman Stefano Pessina received the green light from Alliance Boots’ board for their joint 10.6 ...
DEERFIELD, Ill.--(BUSINESS WIRE)--Walgreens Boots Alliance, Inc. (Nasdaq: WBA) has agreed to the early settlement of certain prepaid variable share forward transactions it had previously entered into ...
Walgreens Boost Alliance (WBA) has decided not sell its Boots and No7 Beauty Company businesses, keeping the combined company intact for now. The company had announced that it was exploring strategic ...
In the latest quarter, 9 analysts provided ratings for Walgreens Boots Alliance (NASDAQ:WBA), showcasing a mix of bullish and bearish perspectives. The following table summarizes their recent ratings, ...
Walgreens Boots Alliance, Inc. reported weak fiscal Q1 2023 results - mostly due to $6.5 billion litigation associated with opioid settlements. And although there are many short-term reasons not to ...
Analysts' ratings for Walgreens Boots Alliance (NASDAQ:WBA) over the last quarter vary from bullish to bearish, as provided by 9 analysts. The table below summarizes their recent ratings, showcasing ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results